Skip to main content
MAXCYTE, INC. logo

MAXCYTE, INC. — Investor Relations & Filings

Ticker · MXCT ISIN · US57777K1060 LEI · 54930053YHXULRFCU991 US Professional, scientific and technical activities
Open in API
Filings indexed 767 across all filing types
Latest filing 2016-06-14 Regulatory Filings
Country US United States of America
Listing US MXCT

About MAXCYTE, INC.

https://www.maxcyte.com/

MaxCyte, Inc. is a cell-engineering company that provides enabling platform technologies to advance the discovery, development, and commercialization of cell-based therapeutics. Its core offering is the ExPERT™ platform, which utilizes proprietary Flow Electroporation® technology for efficient, scalable, and non-viral transfection of complex cells. This technology supports a wide range of applications, including cell therapy, gene editing, antibody and protein production, and vaccine development. Additionally, MaxCyte offers SeQure™ genotoxicity assessment services to evaluate the safety of gene-edited products by detecting on- and off-target effects. The company employs a partnership-driven licensing model to support clients from early-stage research through to clinical and commercial manufacturing.

Recent filings

Filing Released Lang Actions
Grant of options
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from MaxCyte, Inc. regarding the 'Grant of Options' to directors and employees. While it involves directors, it is specifically an announcement of share option grants rather than a report of a personal transaction (Director's Dealing) or a change in board composition (Management Information). Given the nature of the announcement regarding share-based compensation and the RNS format, it fits best under 'Regulatory Filings' as a general corporate announcement.
2016-06-14 English
Publication of Annual Report & Notification of AGM
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) issued via RNS (Regulatory News Service) that explicitly states the company's Annual Report has been published on its website and provides notice of an upcoming AGM. Per the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2016-06-10 English
Maiden Results for the Year Ended 31 Dec 2015
Earnings Release Classification · 95% confidence The document is an official announcement from MaxCyte, Inc. regarding its 'maiden full year audited results' for the year ended 31 December 2015. It contains financial highlights, operational reviews, and a CEO/Chairman's review. While it provides significant detail, it is structured as an RNS (Regulatory News Service) announcement, which is the standard format for initial earnings releases and annual result summaries for companies listed on the London Stock Exchange (AIM). Given the comprehensive nature of the financial data and management commentary provided within the announcement, it functions as an Earnings Release (ER). FY 2015
2016-05-10 English
Notice of Maiden Full Year Results
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) from MaxCyte, Inc. regarding the upcoming release of its full-year results. It explicitly states that the company 'will be announcing its maiden full year results... on Tuesday 10 May 2016'. Following the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, and therefore qualifies as a Report Publication Announcement (RPA).
2016-04-29 English
Issue of Equity from Exercise of Share Options
Share Issue/Capital Change Classification · 100% confidence The document is an announcement from MaxCyte, Inc. regarding the issuance and allotment of new common stock following the exercise of share options. This falls under the category of share capital changes or new share issues. According to the provided definitions, 'SHA' (Share Issue/Capital Change) is the correct classification for announcements regarding new share issues or capital changes.
2016-04-07 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' form, which is the standard regulatory template used in the UK for disclosing significant changes in share ownership (crossing thresholds). The document explicitly identifies the issuer (MaxCyte, Inc.), the person subject to the notification (Legal & General Group Plc), and the details of the voting rights held. This fits the definition of a Major Shareholding Notification (MRQ).
2016-03-30 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.